Dominik Sebastian Westphal

Dr. Dominik Sebastian Westphal

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2021 in Clinical Genetics
Verified
Journal Article
Open access
PDF file
TBTheresa Brunet
Theresa Brunet
RJRobert Jech
Robert Jech
MBMelanie Brugger
Melanie Brugger
RKReka Kovacs
Reka Kovacs
BABader Alhaddad
Bader Alhaddad
MWMatias Wagner
Matias Wagner
Up to 40% of neurodevelopmental disorders (NDDs) such as intellectual disability, developmental delay, autism spectrum disorder, and developmental motor abnormalities have a documented underlying monogenic defect, primarily due to de novo variants. Still, the overall burden of de novo variants as well as novel disease genes in NDDs await discovery. We performed parent‐offspring trio exome sequencing in 231 individuals with NDDs. Phenotypes were compiled using human phenotype ontology terms. The overall diagnostic yield was 49.8% (n = 115/231) with de novo variants contributing to more than 80% (n = 93/115) of all solved cases. De novo variants affected 72 different—mostly constrained—genes. In addition, we identified putative pathogenic variants in 16 genes not linked to NDDs to date. Reanalysis performed in 80 initially unsolved cases revealed a definitive diagnosis in two additional cases. Our study consolidates the contribution and genetic heterogeneity of de novo variants in NDDs highlighting trio exome sequencing as effective diagnostic tool for NDDs. Besides, we illustrate the potential of a trio‐approach for candidate gene discovery and the power of systematic reanalysis of unsolved cases.

17 February 2022 in Nature Cardiovascular Research
Verified
Journal Article
Open access
PDF file
NSNadine Spielmann
Nadine Spielmann
GMGregor Miller
Gregor Miller
TOTudor I. Oprea
Tudor I. Oprea
CHChih-Wei Hsu
Chih-Wei Hsu
GFGisela Fobo
Gisela Fobo
MAMartin M. Hrabě de Angelis
Martin M. Hrabě de Angelis
Clinical presentation of congenital heart disease is heterogeneous, making identification of the disease-causing genes and their genetic pathways and mechanisms of action challenging. By using in vivo electrocardiography, transthoracic echocardiography and microcomputed tomography imaging to screen 3,894 single-gene-null mouse lines for structural and functional cardiac abnormalities, here we identify 705 lines with cardiac arrhythmia, myocardial hypertrophy and/or ventricular dilation. Among these 705 genes, 486 have not been previously associated with cardiac dysfunction in humans, and some of them represent variants of unknown relevance (VUR). Mice with mutations inCasz1,Dnajc18,Pde4dip,Rnf38orTmem161bgenes show developmental cardiac structural abnormalities, with their human orthologs being categorized as VUR. Using UK Biobank data, we validate the importance of theDNAJC18gene for cardiac homeostasis by showing that its loss of function is associated with altered left ventricular systolic function. Our results identify hundreds of previously unappreciated genes with potential function in congenital heart disease and suggest causal function of five VUR in congenital heart disease.

22 July 2024 in Nature Genetics
Verified
Journal Article
Open access
PDF file
ASAxel Schmidt
Axel Schmidt
MDMagdalena Danyel
Magdalena Danyel
KGKathrin Grundmann
Kathrin Grundmann
TBTheresa Brunet
Theresa Brunet
HKHannah Klinkhammer
Hannah Klinkhammer
MWMatias Wagner
Matias Wagner
Individuals with ultrarare disorders pose a structural challenge for healthcare systems since expert clinical knowledge is required to establish diagnoses. In TRANSLATE NAMSE, a 3-year prospective study, we evaluated a novel diagnostic concept based on multidisciplinary expertise in Germany. Here we present the systematic investigation of the phenotypic and molecular genetic data of 1,577 patients who had undergone exome sequencing and were partially analyzed with next-generation phenotyping approaches. Molecular genetic diagnoses were established in 32% of the patients totaling 370 distinct molecular genetic causes, most with prevalence below 1:50,000. During the diagnostic process, 34 novel and 23 candidate genotype–phenotype associations were identified, mainly in individuals with neurodevelopmental disorders. Sequencing data of the subcohort that consented to computer-assisted analysis of their facial images with GestaltMatcher could be prioritized more efficiently compared with approaches based solely on clinical features and molecular scores. Our study demonstrates the synergy of using next-generation sequencing and phenotyping for diagnosing ultrarare diseases in routine healthcare and discovering novel etiologies by multidisciplinary teams.

14 March 2019 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
DWDominik Sebastian Westphal
Dominik Sebastian Westphal
GLGloria S. Leszinski
Gloria S. Leszinski
EREsther Rieger‐Fackeldey
Esther Rieger‐Fackeldey
EGElisabeth Graf
Elisabeth Graf
GWGregor Weirich
Gregor Weirich
MWMatias Wagner
Matias Wagner

8 May 2020 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
PDF file
DWDominik Sebastian Westphal
Dominik Sebastian Westphal
TBTobias Burkard
Tobias Burkard
AMAlexander Moscu‐Gregor
Alexander Moscu‐Gregor
RGRoman Gebauer
Roman Gebauer
GHGabriele Hessling
Gabriele Hessling
CWCordula M. Wolf
Cordula M. Wolf
Background: Genes encoding cardiac ion channels or regulating proteins have been associated with the inherited form of long QT syndrome (LQTS). Complex pathophysiology and missing functional studies, however, often bedevil variant interpretation and classification. We aimed to evaluate the rate of change in variant classification based on current interpretation standards and dependent on clinical findings.Methods: Medical charts of children with a molecular genetic diagnosis of LQTS presenting at our centers were retrospectively reviewed. Reinterpretation of originally reported variants in genes associated with LQTS was performed based on current knowledge (March 2019) and according to the “Standards and Guidelines for the Interpretation of Sequence Variants” by the ACMG 2015.Results: About 84 distinct (likely) pathogenic variants identified in 127 patients were reinterpreted. In 12 variants (12/84, 14.3%), classification changed from (likely) pathogenic to variant of unknown significance (VUS). One of these variants was a hypomorphic allele escaping the standard variant classification. Individuals with variants that downgraded to VUS after reevaluation showed significantly lower Schwartz scores and QTc intervals compared to individuals with unchanged variant characterization.Conclusion: This finding confirms genetic variant interpretation as a dynamic process and underlines the importance of ongoing genetic counseling, especially in LQTS patients with minor clinical criteria.

2 April 2024 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
SSSamin A. Sajan
Samin A. Sajan
RGRalph Gradisch
Ralph Gradisch
FVFlorian D. Vogel
Florian D. Vogel
ACAlison J. Coffey
Alison J. Coffey
DSDaria Salyakina
Daria Salyakina
MKMartin Krenn
Martin Krenn
Nine out of 19 genes encoding GABAA receptor subunits have been linked to monogenic syndromes characterized by seizures and developmental disorders. Previously, we reported the de novo variant p.(Thr300Ile) in GABRA4 in a patient with epilepsy and neurodevelopmental abnormalities. However, no new cases have been reported since then. Through an international collaboration, we collected molecular and phenotype data of individuals carrying de novo variants in GABRA4. Patients and their parents were investigated either by exome or genome sequencing, followed by targeted Sanger sequencing in some cases. All variants within the transmembrane domain, including the previously reported p.(Thr300Ile) variant, were characterized in silico and analyzed by molecular dynamics (MD) simulation studies. We identified three novel de novo missense variants in GABRA4 (NM_000809.4): c.797 C > T, p.(Pro266Leu), c.899 C > A, p.(Thr300Asn), and c.634 G > A, p.(Val212Ile). The p.(Thr300Asn) variant impacts the same codon as the previously reported variant p.(Thr300Ile) and likely arose post-zygotically as evidenced by sequencing oral mucosal cells. Overlapping phenotypes among affected individuals included developmental delay (4/4), epileptiform EEG abnormalities (3/4), attention deficits (3/4), seizures (2/4), autistic features (2/4) and structural brain abnormalities (2/4). MD simulations of the three variants within the transmembrane domain of the receptor indicate that sub-microsecond scale dynamics differ between wild-type and mutated subunits. Taken together, our findings further corroborate an association between GABRA4 and a neurological phenotype including variable neurodevelopmental, behavioral and epileptic abnormalities.